General Information
Revision date
2024-10-28
Product name
Compound E
Product Synonyms
N-[(1S)-2-[[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]amino]-1-methyl-2-oxoethyl]-3,5-difluoro-benzeneacetamide γ-Secretase Inhibitor XXI
CAS No.
209986-17-4
1.2.1 Relevant identified uses
This product is for research use - Not for human or veterinary diagnostic or therapeutic use
Emergency telephone
+1 (734) 971-3335, 800-424-9300
Icons in SDS
Company Information
company name
Cayman Chemical Co
GHS Information
Signal word
None
Section 2
SECTION 2: Hazards identification
NFPA Rating Classification of the substance or mixture The substance is not classified, according to the Globally Harmonized System (GHS)
2.2 Label elements
None
Hazard pictograms
None
Signal word
None
Hazard statements
None · Information pertaining to particular dangers for man and environment
Classification system
· NFPA ratings (scale 0 - 4) Health = 0 0 Fire = 0 0 Reactivity = 0 (Contd. on page 2) US (Contd. from page 1) · HMIS-ratings (scale 0 - 4) HEALTH 0 Health = 0 FIRE 0 Fire = 0 REACTIVITY 0 Reactivity = 0
PBT Substances
Not applicable
vPvB Substances
Not applicable
EU Classification
(d)(1)(ii) of § 1910.12000 The SDS issuer does not object to the classifications provided by importers or manufacturers of precursor products.
2.3 Other hazards
There are no adverse physical or health effects known that are not covered by the hazard classes of the Hazard Communications Standard.
2.1 Classification of the substance or mixture
The substance is not classified, according to the Globally Harmonized System (GHS).
